Kun Chang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Radical Prostatectomy

Prostate Cancer

Top Venues

Molecular cancer research : MCR

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Wen-Hao Xu, Jiahe Lu, Xi Tian, Shiqi Ye, Shiyin Wei, Jun Wang, Aihetaimujiang Anwaier, Yuanyuan Qu, Wang-Rui Liu, Kun Chang, Hai-Liang Zhang, Dingwei Ye
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. MedComm 5 (1) (2024)
Zhe Kong, Yali Lu, Yue Yang, Kun Chang, Yan Lin, Yan Huang, Chenji Wang, Lu Zhang, Wei Xu, Shi-Min Zhao, Yao Li
m6A-mediated biogenesis of circDDIT4 inhibits prostate cancer progression by sequestrating ELAVL1/HuR. Molecular cancer research : MCR (2023)
Kun Chang, Yingji Chen, Xuanzhi Zhang, Wei Zhang, Ning Xu, Bohan Zeng, Yue Wang, Tao Feng, Bo Dai, Fu-Jiang Xu, Dingwei Ye, Chenji Wang
DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma. Cancer research (2023)